What should a patient do if they miss a dose of sodium valproate?

What to Do If a Dose of Sodium Valproate Is Missed

If a patient misses a dose of sodium valproate, they should take it as soon as they remember, then continue with their regular dosing schedule—but critically, they must never abruptly stop taking valproate due to the serious risk of precipitating status epilepticus. 1

Immediate Action for Missed Doses

When a dose is missed, the patient should:

• Take the missed dose immediately upon remembering
• Resume the regular dosing schedule at the next scheduled time
• Do NOT double up doses (take two doses at once)

The FDA labeling explicitly warns that antiepilepsy drugs should not be abruptly discontinued in patients in whom the drug is administered to prevent major seizures because of the strong possibility of precipitating status epilepticus with attendant hypoxia and threat to life 1. This makes addressing missed doses promptly essential for patient safety.

Timing Considerations Based on Research Evidence

Research provides more nuanced guidance based on how long the dose has been delayed:

For immediate-release (enteric-coated) formulations:

• If the dose is missed by ≤12 hours: Take the missed dose immediately, then resume the regular schedule 2
• If the dose is missed by >12 hours: The optimal replacement strategy becomes less clear, particularly in patients taking enzyme-inducing antiepileptics, as replacing the dose may risk transient toxicity 2

For extended-release formulations:

• Missed doses can be replaced up to 12 hours later without clinically significant changes in plasma valproic acid concentrations in most patients 3
• The controlled, near zero-order absorption of extended-release formulations provides more flexibility 3

Critical Safety Considerations

Risk of breakthrough seizures: When valproate doses are missed for extended periods, plasma concentrations can fall below the therapeutic threshold (50 mg/L). Research shows that in patients on polytherapy with enzyme-inducing drugs, missing doses for 18-24 hours can drop mean minimum concentrations to 28-20 mg/L, well below therapeutic levels 2. This substantially increases seizure risk.

Avoid abrupt discontinuation: The evidence consistently emphasizes that 30-40% of people switching from or discontinuing valproate experience breakthrough seizures 4. Missing multiple consecutive doses effectively creates a discontinuation scenario, exposing patients to risks including status epilepticus and Sudden Unexpected Death in Epilepsy (SUDEP).

Practical Patient Counseling

Patients should be advised to:

1. Set reminders to minimize missed doses given valproate's requirement for consistent dosing
2. Contact their healthcare provider if they miss multiple doses or are uncertain about what to do
3. Never compensate for a missed dose by taking double the next dose
4. Monitor for breakthrough seizures after any missed dose, particularly if therapeutic levels were borderline

Special Populations

Elderly patients: These patients have decreased unbound clearance and greater sensitivity to somnolence. They require closer monitoring after any dosing irregularity, with particular attention to fluid and nutritional intake 1.

Patients on polytherapy: Those taking enzyme-inducing antiepileptics (carbamazepine, phenytoin, phenobarbital) have faster valproate clearance and are at higher risk for subtherapeutic levels with missed doses 2.

The overarching principle is that maintaining consistent valproate levels is critical for seizure control, and any missed dose should be addressed promptly while avoiding the temptation to "catch up" with double dosing, which risks toxicity without providing better seizure protection.